China Traditional Chinese Medicine Holdings (HKG:0570) expects its 2024 net profit to decrease by 90% to 100% year over year, according to a filing with the Hong Kong bourse.
The traditional Chinese medicine maker attributed the downbeat forecast to lower sales, credit, goodwill, plant impairment, and remedial taxes paid by subsidiaries.
The company is expected to publish its annual report by March 31.